[HTML][HTML] Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse, X Zhang… - Cancer Cell, 2021 - cell.com
Small cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse… - Cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Small cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
[HTML][HTML] Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse, X Zhang… - Cancer cell, 2021 - ncbi.nlm.nih.gov
Small-cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
[HTML][HTML] Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse, X Zhang… - Cancer Cell, 2021 - Elsevier
Small cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
[HTML][HTML] Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse, X Zhang… - Cancer Cell, 2021 - cell.com
Small cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
[引用][C] Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse, X Zhang… - Cancer Cell, 2021 - cir.nii.ac.jp
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.
A Thomas, N Takahashi, VN Rajapakse, X Zhang… - Cancer Cell, 2021 - europepmc.org
Small-cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse, X Zhang… - paper.sciencenet.cn
Small cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from
diverseprimary sites that lack effective treatments. Using chemical genetic screens, we …
diverseprimary sites that lack effective treatments. Using chemical genetic screens, we …
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
A Thomas, N Takahashi, VN Rajapakse… - Cancer …, 2021 - snucm.elsevierpure.com
Small cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse
primary sites that lack effective treatments. Using chemical genetic screens, we identified …
primary sites that lack effective treatments. Using chemical genetic screens, we identified …